GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Show more...
CEO
직원
437
상장
0 Comments
생각을 공유하기
FAQ
오늘 GenMark Diagnostics 주가는 얼마인가요?▼
GNMK의 현재 가격은 $24.04 USD이며, 지난 24시간 동안 +0% 상승했습니다. 차트에서 GenMark Diagnostics 주가 흐름을 더 자세히 살펴보세요.
GenMark Diagnostics의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, 거래소에서는 GenMark Diagnostics 주식이 GNMK 심볼로 거래됩니다.